218 results on '"Vriens, Dennis"'
Search Results
2. Correction to: Use of [18F]FDG PET/CT for Target Volume Definition in Radiotherapy
3. Non-invasive Imaging Biomarkers of Thyroid Nodules with Indeterminate Cytology
4. Endocriene aandoeningen
5. [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules
6. Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice?
7. [18F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
8. Use of [18F]FDG PET/CT for Target Volume Definition in Radiotherapy
9. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
10. Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules
11. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
12. Review of the role of bone-SPECT/CT in tarsal coalitions
13. 18F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults
14. Defining the imaging diagnostic criteria for adult chronic non-bacterial osteitis.
15. Molecular diagnostics and [18F]FDG-PET/CT in indeterminate thyroid nodules: complementing techniques or waste of valuable resources?
16. Correction to: Use of [18F]FDG PET/CT for Target Volume Definition in Radiotherapy
17. Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT
18. 18F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults.
19. Molecular Diagnostics and [18F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?
20. A clinically applicable molecular classification of oncocytic cell thyroid nodules
21. Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer
22. Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers
23. Considerations on bone volume normalization in quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT
24. Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
25. In reaction to: Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al. Section 5: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022;83:401-6. https://doi.org/10.1016/j.ando.2022.10.008
26. Review of the role of bone-SPECT/CT in tarsal coalitions
27. Use of [18F]FDG PET/CT for Target Volume Definition in Radiotherapy
28. Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma
29. Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
30. [18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
31. Clinical Pharmacology of Radiotheranostics in Oncology
32. 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
33. Preoperative stratification of cytologically indeterminate thyroid nodules by [18F]FDG-PET: can Orpheus bring back Eurydice?
34. Clinical Pharmacology of Radiotheranostics in Oncology.
35. Quantitative Assessment of Heterogeneity in Tumor Metabolism Using FDG-PET
36. [18F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas.
37. 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
38. The Influence of the Exclusion of Central Necrosis on [18F]FDG PET Radiomic Analysis
39. The role of 18F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours
40. Methodological considerations in quantification of oncological FDG PET studies
41. The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy
42. [18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
43. Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
44. Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
45. In reaction to: Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al. Section 5: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022;83:401-6. https://doi.org/10.1016/j.ando.2022.10.008
46. Therapy-Related Imaging Findings in Patients with Sarcoma
47. The role of [18F]-2-fluoro-2-deoxy-d-glucose–positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: Systematic review and meta-analysis of the literature
48. Vascular and Metabolic Response to Bevacizumab-Containing Regimens in Two Patients With Colorectal Liver Metastases Measured by Dynamic Contrast-Enhanced MRI and Dynamic 18F-FDG-PET
49. Adding the temporal domain to PET radiomic features
50. Nuclear medicine radiomics in precision medicine: why we can't do without artificial intelligence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.